XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422LAA5. A total of 6 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $21,409,596 | +23.4% | 18,000,000 | 0.0% | 0.46% | +18.1% |
| Q1 2023 | $17,348,832 | +1.5% | 18,000,000 | 0.0% | 0.39% | +9.3% |
| Q4 2022 | $17,094,600 | -1.7% | 18,000,000 | 0.0% | 0.35% | +2.3% |
| Q3 2022 | $17,384,000 | -1.3% | 18,000,000 | 0.0% | 0.35% | -4.7% |
| Q2 2022 | $17,607,000 | -16.5% | 18,000,000 | 0.0% | 0.36% | -23.1% |
| Q1 2022 | $21,095,000 | -2.2% | 18,000,000 | 0.0% | 0.47% | +4.2% |
| Q4 2021 | $21,577,000 | +14.4% | 18,000,000 | 0.0% | 0.45% | +23.1% |
| Q3 2021 | $18,864,000 | -33.9% | 18,000,000 | 0.0% | 0.37% | -27.4% |
| Q2 2021 | $28,545,000 | -6.2% | 18,000,000 | 0.0% | 0.51% | -20.7% |
| Q1 2021 | $30,417,000 | -3.9% | 18,000,000 | 0.0% | 0.64% | +2.1% |
| Q4 2020 | $31,658,000 | -12.3% | 18,000,000 | 0.0% | 0.63% | -28.8% |
| Q3 2020 | $36,116,000 | +103.7% | 18,000,000 | 0.0% | 0.88% | +70.3% |
| Q2 2020 | $17,732,000 | – | 18,000,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kamunting Street Capital Management, L.P. | 1,500 | $1,508,000 | 1.72% |
| Context Capital Management, LLC | 3,250,000 | $3,202,000 | 1.24% |
| Mohican Financial Management, LLC | 500,000 | $494,000 | 0.89% |
| 683 Capital Management, LLC | 10,000,000 | $10,050,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 18,000,000 | $17,732,000 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 1,500,000 | $1,496,000 | 0.37% |
| Hound Partners | 2,500,000 | $2,476,000 | 0.22% |
| DeepCurrents Investment Group LLC | 6,000,000 | $6,117,000 | 0.22% |
| WHITEBOX ADVISORS LLC | 4,000,000 | $3,941,000 | 0.22% |
| Antara Capital LP | 1,500,000 | $1,485,000 | 0.16% |